1.Factors associated with medication compliance among hypertensive patients in Barangay Sambag II, Cebu City.
Katrina Isabel A. ABESTA ; Stacy Gayle N. AUZA ; Avinash SURAM ; Francis Keith A. OLUDIN ; Jonathan P. ABRENILLA ; Joy Ochoyafie OCHE ; Maria Dawn F. AMANTE ; Millicent C. ABAYAN ; Pamela Kaye B. PANDILI ; Rex Moller Q. PALMES ; Yanilen A. NOYNAY ; Anacleto Clent L. BANAAY JR. ; Marvin C. MASALUNGA
Acta Medica Philippina 2025;59(Early Access 2025):1-7
BACKGROUND
Medication compliance contributes to preventing significant morbidities, such as stroke, among hypertensive patients.
OBJECTIVEThis study aimed to examine the factors affecting hypertensive patients' medication compliance in Sambag II, Cebu City.
METHODSThis study is an observational cross-sectional study. The study was conducted in Barangay Sambag II of Cebu City and involved 170 random, voluntary, self-reporting hypertensive patients. The Tao Yamane formula was used to determine the sample size. An interviewer-guided survey questionnaire was utilized to collect the data for the pilot study. The data were analyzed using Cronbach’s Alpha Test for internal consistency and reliability.
RESULTSThree factors were shown to influence compliance with antihypertensive medications. These are the source of medication, access to medication, and symptoms experienced before intake of anti-hypertensive medications. A factor that significantly affects compliance is the source of medication, wherein hypertensive patients prefer medications from retail pharmacies compared to the free medications supplied by the local health center.
CONCLUSIONResidents of Sambag II, Cebu City preferred medications from retail pharmacies over the free medications provided by the local health center. Local health units may use this information to implement information drugs regarding the efficacy of medications provided by government agencies. Further studies are recommended to use subgroup analysis on factors influencing compliance and non-compliance to anti-hypertensive medicines.
Human ; Medication Compliance ; Medication Adherence ; Hypertension ; Stroke
2.Exploring job satisfaction and performance of staff nurses in Baguio City, Philippines: A descriptive cross-sectional study.
Andrea Dawn N. Sarmiento ; Jasha Amidala S. Rabilas ; Raven Alexander M. Rimada ; Kaye Chelsea E. Rimorin ; Julius Joseph I. Salangsang ; Isiah F. Soriano ; Bianca Liezel L. Tasani ; Rheil Avie A. Ubando ; Keesha Andrea F. Uy ; Noah Keesha R. Valdez ; Christine Joy B. Vergara ; Shaira Mae D. Yabut ; Cheryll M. Bandaay
Philippine Journal of Nursing 2024;94(1):66-74
BACKGROUND
Nursing, as a profession, is a facet where job satisfaction and performance matter. In the changing landscape of nursing practice in the Philippines and the aftermath of the COVID-19 pandemic, it is imperative to revisit and to perform an empirical investigation of the current state of nurses' job satisfaction and performance in the hospital setting. This study aimed to describe the job satisfaction and performance among staff nurses in private and government hospitals in Baguio City.
DESIGNUsing a quantitative descriptive cross-sectional survey design, a sample of 313 randomly selected staff nurses working in two private and two government hospitals in Baguio City were surveyed from March to April 2023, using a questionnaire. This study's protocol was approved by two ethics committees, namely the Saint Louis University Research Ethics Committee and the BGHMC REC. Nominal data was analyzed using the SPSS trial version employing frequencies, percentages, and the Chi-square test.
FINDINGSThere are more staff nurses in both private and government hospitals who reported satisfactory job satisfaction levels (276 nurses, 87.9%) and had good job performance (303 nurses, 96.5%) in all domains. However, results show that there are more nurses (209 nurses, 90.7% ) in government hospitals who are satisfied with their jobs than in private hospital nurses (67 nurses, 80.1%) in the domains Intra practice Partnership/Collegiality (p=0.010); Challenge/Autonomy (p=0.001); Professional, Social and Community Interaction (p=0.010); Professional Growth (p=0.036); Time (p=0.009); and Benefits (p=0.045). In terms of job performance, more government nurses at 97.3% (224 nurses) rated a higher self-appraisal of job performance. In comparison, only 94.8% (79 nurses) of private staff nurses appraised themselves as having good performance. No significant differences were found in the domains of job performance, namely leadership, teaching, planning, communications, and professional development, except in critical care. In "Critical care," which showed significance, the results suggest that more nurses in government hospitals perceive higher job performance, revealing a significant difference (p=0.011) in the "critical care" domain, indicating that a higher proportion of nurses in government hospitals demonstrate superior performance in this area.
CONCLUSIONThrough this study, it was learned that nurses in both private and government hospitals generally experience high job satisfaction and performance, reflecting a fulfilled workforce and indicating commendable competency among the staff nurses. However, more nurses in government hospitals report high satisfaction and perceived performance in critical care compared to those in private hospitals. Thus, the findings of this study can contribute to and serve as a rationale for policy making regarding creating a positive work environment, proper management and leadership, creation of training and skill development for critical care, providing opportunities for professional growth, and conducting regular evaluation and feedback----- all geared towards a satisfied and productive workforce.
Job Satisfaction ; Job Performance ; Work Performance ; Work Environment ; Working Conditions
3.Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study
Harshith THYAGATURU ; Harigopal SANDHYAVENU ; Anoop TITUS ; Nicholas ROMA ; Karthik GONUGUNTLA ; Neel Navinkumar PATEL ; Anas HASHEM ; Jinnette Dawn ABBOTT ; Sudarshan BALLA ; Deepak L. BHATT
Korean Circulation Journal 2024;54(11):710-723
Background and Objectives:
There are limited national data on the trends and outcomes of patients hospitalized with acute myocardial infarction (AMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate the impact of early COVID-19 pandemic on the trends and outcomes of AMI using the National Inpatient Sample (NIS) database.
Methods:
The NIS database was queried from January 2019 to December 2020 to identify adult (age ≥18 years) AMI hospitalizations and were categorized into ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) based on International Classification of Diseases, Tenth Revision, Clinical Modification codes. In addition, the in-hospital mortality, revascularization, and resource utilization of AMI hospitalizations early in the COVID-19 pandemic (2020) were compared to those in the prepandemic period (2019) using multivariate logistic and linear regression analysis.
Results:
Amongst 1,709,480 AMI hospitalizations, 209,450 STEMI and 677,355 NSTEMI occurred in 2019 while 196,230 STEMI and 626,445 NSTEMI hospitalizations occurred in 2020. Compared with those in 2019, the AMI hospitalizations in 2020 had higher odds of inhospital mortality (adjusted odds ratio [aOR], 1.27; 95% confidence interval [CI], [1.23–1.32];p<0.01) and lower odds of percutaneous coronary intervention (aOR, 0.95 [0.92–0.99];p=0.02), and coronary artery bypass graft (aOR, 0.90 [0.85–0.97]; p<0.01).
Conclusions
We found a significant decline in AMI hospitalizations and use of revascularization, with higher in-hospital mortality, during the early COVID-19 pandemic period (2020) compared with the pre-pandemic period (2019). Further research into the factors associated with increased mortality could help with preparedness in future pandemics.
4.Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study
Harshith THYAGATURU ; Harigopal SANDHYAVENU ; Anoop TITUS ; Nicholas ROMA ; Karthik GONUGUNTLA ; Neel Navinkumar PATEL ; Anas HASHEM ; Jinnette Dawn ABBOTT ; Sudarshan BALLA ; Deepak L. BHATT
Korean Circulation Journal 2024;54(11):710-723
Background and Objectives:
There are limited national data on the trends and outcomes of patients hospitalized with acute myocardial infarction (AMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate the impact of early COVID-19 pandemic on the trends and outcomes of AMI using the National Inpatient Sample (NIS) database.
Methods:
The NIS database was queried from January 2019 to December 2020 to identify adult (age ≥18 years) AMI hospitalizations and were categorized into ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) based on International Classification of Diseases, Tenth Revision, Clinical Modification codes. In addition, the in-hospital mortality, revascularization, and resource utilization of AMI hospitalizations early in the COVID-19 pandemic (2020) were compared to those in the prepandemic period (2019) using multivariate logistic and linear regression analysis.
Results:
Amongst 1,709,480 AMI hospitalizations, 209,450 STEMI and 677,355 NSTEMI occurred in 2019 while 196,230 STEMI and 626,445 NSTEMI hospitalizations occurred in 2020. Compared with those in 2019, the AMI hospitalizations in 2020 had higher odds of inhospital mortality (adjusted odds ratio [aOR], 1.27; 95% confidence interval [CI], [1.23–1.32];p<0.01) and lower odds of percutaneous coronary intervention (aOR, 0.95 [0.92–0.99];p=0.02), and coronary artery bypass graft (aOR, 0.90 [0.85–0.97]; p<0.01).
Conclusions
We found a significant decline in AMI hospitalizations and use of revascularization, with higher in-hospital mortality, during the early COVID-19 pandemic period (2020) compared with the pre-pandemic period (2019). Further research into the factors associated with increased mortality could help with preparedness in future pandemics.
5.Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study
Harshith THYAGATURU ; Harigopal SANDHYAVENU ; Anoop TITUS ; Nicholas ROMA ; Karthik GONUGUNTLA ; Neel Navinkumar PATEL ; Anas HASHEM ; Jinnette Dawn ABBOTT ; Sudarshan BALLA ; Deepak L. BHATT
Korean Circulation Journal 2024;54(11):710-723
Background and Objectives:
There are limited national data on the trends and outcomes of patients hospitalized with acute myocardial infarction (AMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate the impact of early COVID-19 pandemic on the trends and outcomes of AMI using the National Inpatient Sample (NIS) database.
Methods:
The NIS database was queried from January 2019 to December 2020 to identify adult (age ≥18 years) AMI hospitalizations and were categorized into ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) based on International Classification of Diseases, Tenth Revision, Clinical Modification codes. In addition, the in-hospital mortality, revascularization, and resource utilization of AMI hospitalizations early in the COVID-19 pandemic (2020) were compared to those in the prepandemic period (2019) using multivariate logistic and linear regression analysis.
Results:
Amongst 1,709,480 AMI hospitalizations, 209,450 STEMI and 677,355 NSTEMI occurred in 2019 while 196,230 STEMI and 626,445 NSTEMI hospitalizations occurred in 2020. Compared with those in 2019, the AMI hospitalizations in 2020 had higher odds of inhospital mortality (adjusted odds ratio [aOR], 1.27; 95% confidence interval [CI], [1.23–1.32];p<0.01) and lower odds of percutaneous coronary intervention (aOR, 0.95 [0.92–0.99];p=0.02), and coronary artery bypass graft (aOR, 0.90 [0.85–0.97]; p<0.01).
Conclusions
We found a significant decline in AMI hospitalizations and use of revascularization, with higher in-hospital mortality, during the early COVID-19 pandemic period (2020) compared with the pre-pandemic period (2019). Further research into the factors associated with increased mortality could help with preparedness in future pandemics.
6.Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study
Harshith THYAGATURU ; Harigopal SANDHYAVENU ; Anoop TITUS ; Nicholas ROMA ; Karthik GONUGUNTLA ; Neel Navinkumar PATEL ; Anas HASHEM ; Jinnette Dawn ABBOTT ; Sudarshan BALLA ; Deepak L. BHATT
Korean Circulation Journal 2024;54(11):710-723
Background and Objectives:
There are limited national data on the trends and outcomes of patients hospitalized with acute myocardial infarction (AMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate the impact of early COVID-19 pandemic on the trends and outcomes of AMI using the National Inpatient Sample (NIS) database.
Methods:
The NIS database was queried from January 2019 to December 2020 to identify adult (age ≥18 years) AMI hospitalizations and were categorized into ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) based on International Classification of Diseases, Tenth Revision, Clinical Modification codes. In addition, the in-hospital mortality, revascularization, and resource utilization of AMI hospitalizations early in the COVID-19 pandemic (2020) were compared to those in the prepandemic period (2019) using multivariate logistic and linear regression analysis.
Results:
Amongst 1,709,480 AMI hospitalizations, 209,450 STEMI and 677,355 NSTEMI occurred in 2019 while 196,230 STEMI and 626,445 NSTEMI hospitalizations occurred in 2020. Compared with those in 2019, the AMI hospitalizations in 2020 had higher odds of inhospital mortality (adjusted odds ratio [aOR], 1.27; 95% confidence interval [CI], [1.23–1.32];p<0.01) and lower odds of percutaneous coronary intervention (aOR, 0.95 [0.92–0.99];p=0.02), and coronary artery bypass graft (aOR, 0.90 [0.85–0.97]; p<0.01).
Conclusions
We found a significant decline in AMI hospitalizations and use of revascularization, with higher in-hospital mortality, during the early COVID-19 pandemic period (2020) compared with the pre-pandemic period (2019). Further research into the factors associated with increased mortality could help with preparedness in future pandemics.
7.Incidence of Venous Thromboembolism after Primary Total Hip Arthroplasty with Mechanical Prophylaxis in Hong Kong Chinese
Daniel Wai-Yip WONG ; Qunn-Jid LEE ; Chi-Kin LO ; Kenneth Wing-Kin LAW ; Dawn Hei WONG
Hip & Pelvis 2024;36(2):108-119
Purpose:
The incidence of deep vein thrombosis (DVT) following total hip arthroplasty (THA) without chemoprophylaxis could be as high as 50% in Caucasians. However, according to several subsequent studies, the incidence of venous thromboembolic events (VTE) in Asians was much lower. The routine use of chemoprophylaxis, which could potentially cause increased bleeding, infection, and wound complications, has been questioned in low-incidence populations. The objective of this study is to determine the incidence of VTE after primary THA without chemoprophylaxis in an Asian population using a fast-track rehabilitation protocol and to verify the safety profile for use of ‘mechanical prophylaxis alone’ in patients with standard risk of VTE.
Materials and Methods:
This is a retrospective cohort study of 542 Hong Kong Chinese patients who underwent primary THA without chemoprophylaxis. All patients received intermittent pneumatic compression and graduated compression stockings as mechanical prophylaxis. Multimodal pain management was applied in order to facilitate early mobilisation. Routine duplex ultrasonography was performed between the fourth and seventh postoperative day for detection of proximal DVT.
Results:
All patients were Chinese (mean age, 63.0±11.9 years). Six patients developed proximal DVT (incidence rate, 1.1%). None of the patients had symptomatic or fatal pulmonary embolism.
Conclusion
The incidence of VTE after primary THA without chemical prophylaxis can be low in Asian populations when following a fast-track rehabilitation protocol. Mechanical prophylaxis alone can be regarded as a reasonably safe practice in terms of a balanced benefit-to-risk ratio for Asian patients with standard risk of VTE.
8.Laparoscopic pancreas-preserving near total duodenectomy for large villous adenoma in patients with total colectomy for familial adenomatous polyposis
Dawn JUNG ; Ji Eun JUNG ; Chang Moo KANG
Journal of Minimally Invasive Surgery 2023;26(2):83-87
Most familial adenomatous polyposis (FAP) patients undergo total colectomy, but duodenal polyposis develops in up to 90% of patients with FAP and a 4% to 18% risk of duodenal and ampullary cancer remains. Laparoscopic pancreas-preserving near total duodenectomy is thought to be a potential option and can be an effective approach to preserve the pancreas. A 48-year-old male patient, who underwent laparoscopic total colectomy with end ileostomy because of FAP with colorectal cancer, was diagnosed with a 20 mm-sized duodenal adenoma in the second to the third portion. The operation was performed on December 27, 2021. Near total duodenectomy was done and type II Billroth gastrojejunostomy was done. Laparoscopic pancreas-sparing duodenectomy is shown to be safe, with favorable short-term oncologic outcome compared to laparoscopic pancreatoduodenectomy in terms of less blood loss, faster recovery time, and much less total cost.
9.Clinical characteristics and outcomes of coronavirus disease 2019-infected adult cancer patients in the Philippines from March to December 2020
Mary Ondinee Igot, MD ; Brylle Caesar Dala, MD ; Jonas Planilla, MD ; Marvin Mendoza, MD ; Anna Flor Gaboy-Malundo, MD ; Perlita Yu-Dela Cruz, MD ; Kenny Jun Demegillo, MD ; Kathryn Roa, MD ; Melina Barzaga, MD ; Diane Buendia, MD ; Dawn Guardiario, MD ; Gerardo Cornelio, MD ; Danielle Benedict Sacdalan, MD
Philippine Journal of Internal Medicine 2023;61(2):52-56
Background:
Data on the clinical characteristics and outcomes of Filipino cancer patients who acquired the coronavirus
disease 2019 (COVID-19) are limited and local information is lacking. Here we characterize the outcomes of patients with
cancer and COVID-19.
Methods:
Medical records of Filipino cancer patients with COVID-19 from the University of the Philippines – Philippine
General Hospital (UP-PGH), Southern Philippines Medical Center (SPMC), De La Salle – University Medical Center (DLS-
UMC), and St Luke’s Medical Center (SLMC) from March to December 2020 were reviewed.
Results:
Sixty-nine cancer patients were identified to have COVID-19. The mean age was 53 years (range 19-88) and 45
(65%) patients were female. The most prevalent malignancies were from the gastrointestinal tract (16 [23%]) and the breast
(14 [20%]). The majority (34 [49%]) had metastatic disease and had a functional status of Eastern Cooperative Oncology
Group (ECOG) 2 or worse (39 [57%]). Forty-two (61%) patients had active oncologic treatment given for the past three
months and twenty-four (35%) of these patients were on chemotherapy. The most common symptoms upon presentation
were cough (34 [49%]) followed by dyspnea (28 [41%]). COVID-19 severity of this series was as follows: 15 mild (22%), 32
moderate (46%), 7 severe (10%), and 15 critical (22%). The majority received intravenous antibiotics (54 [78%]),
investigational treatments (27 [39%]), and steroids (20 [29%]). Common complications were acute respiratory failure (20
[29%]), acute respiratory distress syndrome (17 [25]), and septic shock (15 [22%]). At the end of the collection period, 21
(30%) cancer patients died. The mean length of hospital stay was 22 days.
Conclusion
Based on the findings of our case series, ECOG 2 and higher, metastatic stage, higher neutrophil to
lymphocyte ratio showed a trend to worse outcomes. Cancer-related treatment within the past months did not appear to
affect outcomes.
COVID-19
;
SARS-COV2
;
Cancer
;
Philippines
10.Which one will you choose; open, laparoscopic, or robotic transduodenal ampullectomy?: a case report
Dawn JUNG ; Ji Eun JUNG ; Chang Moo KANG
Journal of Minimally Invasive Surgery 2022;25(2):73-76
Transduodenal ampullectomy (TDA) is the treatment of choice for large premalignant lesions of the ampulla of Vater (AoV). With the development of surgical techniques, various methods, including the open, laparoscopic, and robotic approaches, for performing TDA have emerged. Herein, we report four consecutive cases treated with open, laparoscopic, and robotic TDA, with technical pitfalls and future perspectives of TDA in treating premalignant lesions of the AoV. The surgical techniques and principles for TDA were the same regardless of the surgical approaches. After surgery, none of the patients showed any abnormal findings or complications, except for digestive problems. All these surgical approaches are appropriate for patients requiring TDA; however, minimally invasive TDA, particularly the robotic approach is ideal. Considering the surgical complexity of TDA, the robotic approach is considered to be effective.


Result Analysis
Print
Save
E-mail